[1]
1Cell Death Research and Therapy Laboratory, Department of Cellular Molecular Medicine,
KU Leuven – University of Leuven , Leuven, Belgium
[2]
2Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers , Paris, France
[3]
3U1138, INSERM , Paris, France
[4]
4Université Paris Descartes, Sorbonne Paris Cité , Paris, France
[5]
5Université Pierre et Marie Curie , Paris, France
[6]
6Gustave Roussy Comprehensive Cancer Institute , Villejuif, France
[7]
7U866, INSERM , Dijon, France
[8]
8Faculté de Médecine, Université de Bourgogne , Dijon, France
[9]
9Centre Georges François Leclerc , Dijon, France
[10]
10Department of Gynaecology and Obstetrics, UZ Leuven , Leuven, Belgium
[11]
11Laboratory of Gynaecologic Oncology, Department of Oncology, Leuven Cancer Institute,
KU Leuven , Leuven, Belgium
[12]
12Department of Microbiology, Biochemistry, and Molecular Genetics, University Hospital
Cancer Center, Rutgers Cancer Institute of New Jersey, New Jersey Medical School , Newark, NJ, USA
[13]
13Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel , Jette, Belgium
[14]
14Faculty of Life Sciences, University of Manchester , Manchester, UK
[15]
15Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University
Erlangen-Nurnberg , Erlangen, Germany
[16]
16Department of Experimental Medicine, Sapienza University of Rome , Rome, Italy
[17]
17de Duve Institute, Université Catholique de Louvain , Brussels, Belgium
[18]
18Department of Radiation Oncology, University Hospitals Leuven, KU Leuven – University
of Leuven , Leuven, Belgium
[19]
19Department of Biological and Environmental Science and Technology, University of Salento , Salento, Italy
[20]
20Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological
Sciences, KU Leuven – University of Leuven , Leuven, Belgium
[21]
21Sapienza University of Rome , Rome, Italy
[22]
22SOTIO , Prague, Czech Republic
[23]
23Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles
University , Prague, Czech Republic
[24]
24Department of Radiation Oncology, Universitätsklinikum Erlangen , Erlangen, Germany
[25]
25Department of Immunology, Medical University of Warsaw , Warsaw, Poland
[26]
26Biotherapy and Vaccine Unit, Institut Pasteur , Paris, France
[27]
27Wellman Center for Photomedicine, Massachusetts General Hospital , Boston, MA, USA
[28]
28Cancer Gene Therapy Group, Transplantation Laboratory, Haartman Institute, University
of Helsinki , Helsinki, Finland
[29]
29Helsinki University Hospital Comprehensive Cancer Center , Helsinki, Finland
[30]
30TILT Biotherapeutics Ltd. , Helsinki, Finland
[31]
31Recombinant Vaccine Group, Laboratory of Tumor Immunology and Biology, National Cancer
Institute, National Institutes of Health , Bethesda, MD, USA
[32]
32Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute , Villejuif, France
[33]
33Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP , Paris, France
[34]
34Department of Women’s and Children’s Health, Karolinska University Hospital , Stockholm, Sweden
[35]
35Molecular Signaling and Cell Death Unit, Inflammation Research Center, VIB , Ghent, Belgium
[36]
36Department of Biomedical Molecular Biology, Ghent University , Ghent, Belgium
[37]
37Molecular ImmunoRheumatology, INSERM UMRS1109, Laboratory of Excellence Transplantex,
University of Strasbourg , Strasbourg, France
[38]
38Institute of Molecular Biosciences, NAWI Graz, University of Graz , Graz, Austria
[39]
39BioTechMed Graz , Graz, Austria
[40]
40IRRCS Istituto Scientifico San Raffaele, Università Vita-Salute San Raffaele , Milan, Italy
[41]
41Translational Research Institute, University of Queensland Diamantina Institute, University
of Queensland , Wooloongabba, QLD, Australia
[42]
42Laboratory of Cellular and Molecular Nutrition, Department of Ecological and Biological
Sciences, Tuscia University , Viterbo, Italy
[43]
43Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität
München , Munich, Germany
[44]
44Department of Medical Oncology, University Hospital , Bern, Switzerland
[45]
45INSERM, U1065, Université de Nice-Sophia-Antipolis, Centre Méditerranéen de Médecine
Moléculaire (C3M), Équipe “Contrôle Métabolique des Morts Cellulaires” , Nice, France
[46]
46Department of Oncology, University of Turin , Turin, Italy
[47]
47Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Insitute , Herston, QLD, Australia
[48]
48School of Medicine, University of Queensland , Herston, QLD, Australia
[49]
49Department of Paediatric Haematology and Oncology, Children’s Clinic, Jena University
Hospital , Jena, Germany
[50]
50Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Institut du
Cancer de Montréal, Faculté de Pharmacie, Université de Montréal , Montreal, QC, Canada
[51]
51Laboratory of Pediatric Immunology, Department of Microbiology and Immunology, KU
Leuven – University of Leuven , Leuven, Belgium
[52]
52Ludwig Institute for Cancer Research, de Duve Institute, Université Catholique de
Louvain , Brussels, Belgium
[53]
53Department of Ecological and Biological Sciences, Tuscia University , Viterbo, Italy
[54]
54University of Paris Sud , Le Kremlin-Bicêtre, France
[55]
55U1015, INSERM , Villejuif, France
[56]
56Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507 , Villejuif, France
License:
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
